It has been shown that CAD patients had low serum levels of brain‐derived neurotrophic factor (BDNF), which has a cognitive enhancer effect and negatively correlates with the risk of cognitive impairment and Alzheimer's disease (AD) [13]. Here, BDNF is linked to Alzheimer disease.